🇺🇸 FDA
Pipeline program

Venues-P Valve

PPVI-2013

Phase 3 other active

Quick answer

Venues-P Valve for Pulmonary Regurgitation is a Phase 3 program (other) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Pulmonary Regurgitation
Phase
Phase 3
Modality
other
Status
active

Clinical trials